Skip to main content
Charles Fuchs, MD, Oncology, New Haven, CT

Charles Stewart Fuchs MD

Gastrointestinal Cancer, Hematologic Oncology


Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital Richard and Jonathan Sackler Professor of Internal Medicine, Yale School of Medicine

Join to View Full Profile
  • 333 Cedar StYale Cancer CenterNew Haven, CT 06510

  • Phone+1 203-785-7870

  • Fax+1 203-785-4116

Dr. Fuchs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1986

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 1988 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Boston Magazine Castle Connolly, 2008, 2010-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer  
    Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature

Lectures

  • A phase II trial of [fam-] trastuzumab deruxtecan (T-DXd, DS-8201a) in subjects with HER2-positive, unresectable, or metastatic gastric or gastroesophageal junction (G... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Lifestyle Factors & Cancer Survival Prediction Models
    Lifestyle Factors & Cancer Survival Prediction ModelsFebruary 28th, 2022
  • A Book Draws on 50 Years of Accumulated Wisdom, Calls for “A New Deal for Cancer”
    A Book Draws on 50 Years of Accumulated Wisdom, Calls for “A New Deal for Cancer”December 10th, 2021
  • Yale Cancer Center Experts Co-Author Book on War on Cancer
    Yale Cancer Center Experts Co-Author Book on War on CancerNovember 16th, 2021
  • Join now to see all

Grant Support

  • A Prospective Study Of Diet And Colorectal NeoplasiaNational Cancer Institute2010–2011
  • Prospective Cohort Collaborative In Pancreatic Cancer Epidemiology &PathogenesisNational Cancer Institute2007–2011
  • Dietary And Lifestyle Determinants Of Colon Cancer Recurrence And SurvivalNational Cancer Institute2007–2011
  • Df/Hcc Spore In Gastrointestinal CancerNational Cancer Institute2007–2011
  • Defining Optimal Doses Of Vitamin D For Chemoprevention In African AmericansNational Cancer Institute2007–2011
  • A Prospective Study Of Diet And Colorectal NeoplasiaNational Cancer Institute2007–2009
  • Administration, Evaluation, And PlanningNational Cancer Institute2007
  • Prospective Study Of Pancreatic Cancer PathogenesisNational Cancer Institute2000–2004
  • Prospective Study Of Diet And Colorectal NeoplasiaNational Cancer Institute2001–2002
  • Family History And The Risk Of Common MalignanciesNational Cancer Institute1995–1999

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: